Overview:Fagron's mission is to optimize and innovate personalized pharmaceutical care.
Fagron was founded in the Netherlands (Rotterdam) in 1990. Through a continuous focus on innovation, quality and solution-oriented thinking, Fagron obtained market leadership in pharmaceutical compounding. Today, our team develops, innovates and produces innovative concepts, products and formulas for compounding pharmacies, prescribers and patients in 35 countries worldwide.
More than 2.600 employees are located in offices, compounding facilities and plants in Fagron's key regions Benelux, Europe, North America, South America and the Pacific. The Belgian company Fagron NV is located in Waregem and is listed on Euronext Brussels and Euronext Amsterdam.